Member Login
  1. Stocks
    2. /
  2. Indivior Plc (LSE: INDV)
    3. /

LSE:INDV (Indivior Plc)

About INDV

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Indivior Plc (LSE: INDV) Latest News

    Investing Articles

    Why this beaten-up FTSE 100 dividend stock could be a bargain

    | Roland Head

    Roland Head explains why he'd buy this 6% yielder from the FTSE 100 (INDEXFTSE:UKX).

    Read more »

    Investing Articles

    Why I think Indivior plc is a growth stock for shrewd investors

    | Rupert Hargreaves

    You shouldn't count out Indivior plc (LSE: INDV) just yet.

    Read more »

    Investing Articles

    Why I’d avoid Indivior plc today after shares crash 35%

    | Peter Stephens

    Indivior plc (LON: INDV) is one of today's major fallers.

    Read more »

    Investing Articles

    This great value stock is a better bet than Sirius Minerals plc

    | Royston Wild

    Royston Wild looks at a stock with more investment appeal than Sirius Minerals plc (LON: SXX).

    Read more »

    Investing Articles

    2 value stocks to consider in an expensive market: Indivior plc and Impellam Group plc

    | Jack Tang

    Should you buy Indivior plc (LON:INDV) and Impellam Group plc (LON:IPEL) as value plays following today's announcements?

    Read more »

    Investing Articles

    These 2 FTSE 250 flyers are up 60% in just 12 months

    | Harvey Jones

    Investors in these two FTSE 250 (INDEXFTSE:MCX) companies have plenty to celebrate, says Harvey Jones.

    Read more »

    Investing Articles

    2 top value stocks you should consider buying right now

    | Royston Wild

    Royston Wild runs the rule over two white-hot bargain stocks.

    Read more »

    Investing Articles

    Will this spin-off stock continue to slay FTSE 100 giants?

    | Roland Head

    Roland Head asks if this potential FTSE 100 (INDEXFTSE:UKX) giant killer is worth the risk.

    Read more »

    Investing Articles

    2 fast-growing FTSE 250 stocks for a prosperous 2017

    | Roland Head

    It could pay to take a closer look at these surprise winners, says Roland Head.

    Read more »

    Investing Articles

    Why AstraZeneca plc may still not be cheap enough to beat this upstart

    | Roland Head

    Roland Head takes a look at the latest figures from AstraZeneca plc (LON:AZN) and considers a potential alternative.

    Read more »

    Investing Articles

    The Good, the Bad and the Ugly of pharma stocks

    | Bilaal Mohamed

    Bilaal Mohamed reveals his best and worst picks from the pharmaceuticals sector.

    Read more »

    Investing Articles

    Should you snap up these two big fallers today?

    | Alan Oscroft

    We've got some big movers today, and share price falls can lead to nice bargains. Are these two worth snapping…

    Read more »